The WACC of Heron Therapeutics Inc (HRTX) is 7.7%.
| Range | Selected | |
| Cost of equity | 7.20% - 10.10% | 8.65% |
| Tax rate | 26.20% - 27.00% | 26.60% |
| Cost of debt | 5.30% - 7.00% | 6.15% |
| WACC | 6.4% - 9.0% | 7.7% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.71 | 0.94 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.20% | 10.10% |
| Tax rate | 26.20% | 27.00% |
| Debt/Equity ratio | 0.31 | 0.31 |
| Cost of debt | 5.30% | 7.00% |
| After-tax WACC | 6.4% | 9.0% |
| Selected WACC | 7.7% | |